content

Eli Lilly Invests In Actinium-225 To Support Radiopharma

The largest pharmaceutical company in the world based on market value, Eli Lilly, is getting into the nuclear isotope manufacturing industry as cancer medicine...

Regulatory Challenges In Radiopharmaceuticals And The CAGT

The life sciences industry is going through a big change right now, thanks to the fast growth of new treatments like cell and gene...

IAEA Unveils New Database For Global Radiopharmaceuticals

Research, cooperation, and the sustainability of safe radiopharmaceuticals for clinical application will be aided by a new IAEA radiopharmacy database. To compile into the...

How Are ADCs Improving Cancer Treatments With Precision

ADCs could lead to better and more efficient treatments in the complex and specialized field of tailored cancer medicines. ADCs are made up of...

Antibody Drug Conjugates: Future Therapies And Treatment

Beyond cancer, there are a number of sectors that provide considerable prospects for antibody drug conjugates (ADCs), using their capacity to deliver therapeutic drugs...

Advancements In ADCs: Important Trends And Market Insights

Antibody drug conjugates (ADCs) are the main players in the fields of cancer clinical research and deal-making, with new alliances and contracts appearing on...

BIO Asia-Taiwan 2024 concludes successfully

Number of visitors and business opportunities reach new highs Inaugural BIO Asia Awards presented, and expansion of conference into three tracks highlight Taiwan as important...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read